Health Canada expedited approval of Omega Laboratories' muscle relaxant rocuronium bromide and Accord Healthcare's anti-nausea drug ondansetron to ease a nationwide shortage. "Under normal circumstances, we plan to complete market authorizations for generic drugs within six months," the regulator said. "However, to help health care providers get access to replacement supplies of drugs that they normally get from Sandoz ... we have committed to expediting all phases of the drug-review process as much as possible."

Full Story:
Toronto Sun

Related Summaries